| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2023 | 142.75% | Benchmark | → $67 | Reiterates | Buy → Buy |
| 11/01/2023 | 41.3% | UBS | $40 → $39 | Upgrades | Neutral → Buy |
| 11/01/2023 | 63.04% | Barclays | $52 → $45 | Maintains | Overweight |
| 10/25/2023 | 92.03% | Goldman Sachs | $61 → $53 | Maintains | Buy |
| 10/16/2023 | 12.32% | JP Morgan | $40 → $31 | Maintains | Neutral |
| 10/16/2023 | 12.32% | Bernstein | $55 → $31 | Downgrades | Outperform → Market Perform |
| 10/13/2023 | 142.75% | Benchmark | → $67 | Maintains | Buy |
| 10/13/2023 | 55.8% | Citigroup | $64 → $43 | Maintains | Buy |
| 10/13/2023 | 19.56% | Morgan Stanley | $55 → $33 | Downgrades | Overweight → Equal-Weight |
| 10/13/2023 | 15.94% | Macquarie | $52 → $32 | Downgrades | Outperform → Neutral |
| 09/06/2023 | 41.3% | Loop Capital | $42 → $39 | Maintains | Hold |
| 08/31/2023 | 37.68% | Susquehanna | $40 → $38 | Maintains | Neutral |
| 08/18/2023 | 44.93% | JP Morgan | $43 → $40 | Maintains | Neutral |
| 08/17/2023 | 131.88% | Citigroup | $68 → $64 | Maintains | Buy |
| 08/17/2023 | 117.39% | Mizuho | $70 → $60 | Maintains | Buy |
| 08/17/2023 | 84.78% | B of A Securities | $56 → $51 | Maintains | Buy |
| 07/14/2023 | 164.49% | Benchmark | $72 → $73 | Maintains | Buy |
| 05/18/2023 | 44.93% | Susquehanna | $45 → $40 | Maintains | Neutral |
| 05/12/2023 | 160.87% | Benchmark | $68 → $72 | Maintains | Buy |
| 05/10/2023 | 44.93% | Loop Capital | $49 → $40 | Maintains | Hold |
| 05/09/2023 | 153.62% | Mizuho | $80 → $70 | Maintains | Buy |
| 04/13/2023 | 55.8% | UBS | $60 → $43 | Downgrades | Buy → Neutral |
| 04/13/2023 | 88.41% | Barclays | $74 → $52 | Maintains | Overweight |
| 04/11/2023 | 146.38% | Citigroup | $83 → $68 | Maintains | Buy |
| 03/31/2023 | 77.54% | Loop Capital | $82 → $49 | Downgrades | Buy → Hold |
| 03/13/2023 | 63.04% | Susquehanna | $62 → $45 | Maintains | Neutral |
| 03/13/2023 | 168.11% | Barclays | $72 → $74 | Maintains | Overweight |
| 03/10/2023 | 175.36% | Benchmark | → $76 | Reiterates | → Buy |
| 03/10/2023 | 153.62% | HSBC | $82 → $70 | Maintains | Buy |
| 02/07/2023 | 207.97% | Mizuho | $82 → $85 | Maintains | Buy |
| 11/21/2022 | 226.09% | Citigroup | $85 → $90 | Maintains | Buy |
| 10/28/2022 | 113.77% | Barclays | $66 → $59 | Maintains | Overweight |
| 10/11/2022 | 207.97% | Citigroup | $91 → $85 | Maintains | Buy |
| 09/12/2022 | 124.64% | Susquehanna | $55 → $62 | Maintains | Neutral |
| 07/12/2022 | 236.96% | Citigroup | $90 → $93 | Maintains | Buy |
| 07/12/2022 | 222.46% | Goldman Sachs | $98 → $89 | Maintains | Buy |
| 05/19/2022 | 99.27% | Susquehanna | $66 → $55 | Maintains | Neutral |
| 05/18/2022 | 284.06% | Benchmark | $117 → $106 | Maintains | Buy |
| 05/16/2022 | 110.14% | JP Morgan | $40 → $58 | Upgrades | Underweight → Neutral |
| 05/02/2022 | 226.09% | Mizuho | $100 → $90 | Maintains | Buy |
| 03/14/2022 | 26.81% | JP Morgan | $100 → $35 | Downgrades | Overweight → Underweight |
| 03/11/2022 | 258.69% | Barclays | $103 → $99 | Maintains | Overweight |
| 03/11/2022 | 258.69% | Citigroup | $109 → $99 | Maintains | Buy |
| 03/11/2022 | 229.71% | HSBC | $100 → $91 | Maintains | Buy |
| 03/07/2022 | 207.97% | Morgan Stanley | $98 → $85 | Maintains | Overweight |
| 01/11/2022 | 262.32% | Atlantic Equities | → $100 | Initiates Coverage On | → Overweight |
| 11/19/2021 | 262.32% | Mizuho | $95 → $100 | Maintains | Buy |
| 11/03/2021 | 255.07% | Barclays | → $98 | Initiates Coverage On | → Overweight |
| 08/24/2021 | 207.97% | Mizuho | $95 → $85 | Maintains | Buy |
| 08/24/2021 | 269.56% | Benchmark | $112 → $102 | Maintains | Buy |
| 07/27/2021 | 124.64% | DZ Bank | → $62 | Downgrades | Buy → Sell |
| 05/21/2021 | 189.85% | Susquehanna | $90 → $80 | Maintains | Neutral |
| 05/20/2021 | 305.8% | Benchmark | $122 → $112 | Maintains | Buy |
| 05/20/2021 | 222.46% | HSBC | $98 → $89 | Maintains | Buy |
| 05/12/2021 | 244.2% | Stifel | $105 → $95 | Maintains | Buy |
| 04/15/2021 | 255.07% | HSBC | $108 → $98 | Maintains | Buy |
| 03/12/2021 | 291.3% | HSBC | $103 → $108 | Maintains | Buy |
| 01/25/2021 | — | Bernstein | Initiates Coverage On | → Outperform | |
| 01/05/2021 | 280.43% | Stifel | → $105 | Upgrades | Hold → Buy |
| 06/30/2020 | 171.74% | Mizuho | $62 → $75 | Maintains | Buy |
| 05/19/2020 | 142.75% | CFRA | $48 → $67 | Maintains | Buy |
| 05/18/2020 | 131.88% | Nomura | $54 → $64 | Maintains | Buy |
| 05/18/2020 | 81.16% | Stifel | $43 → $50 | Maintains | Hold |
| 05/18/2020 | 117.39% | B of A Securities | $51 → $60 | Reiterates | → Buy |
| 05/18/2020 | 124.64% | Mizuho | $58 → $62 | Maintains | Buy |
| 05/13/2020 | 110.14% | Mizuho | $37 → $58 | Upgrades | Neutral → Buy |
| 05/04/2020 | 73.91% | CFRA | → $48 | Initiates Coverage On | → Buy |
| 04/15/2020 | 84.78% | Morgan Stanley | → $51 | Upgrades | Equal-Weight → Overweight |
| 03/17/2020 | 88.41% | Bernstein | $41 → $52 | Upgrades | Market Perform → Outperform |
| 03/03/2020 | 117.39% | Benchmark | $42 → $60 | Maintains | Buy |
| 03/03/2020 | 88.41% | JP Morgan | $50 → $52 | Maintains | Overweight |
| 03/03/2020 | 81.16% | China Renaissance | → $50 | Upgrades | Hold → Buy |
| 02/24/2020 | 70.29% | Barclays | $45 → $47 | Maintains | Overweight |
| 01/22/2020 | 70.29% | DZ Bank | → $47 | Initiates Coverage On | → Buy |
| 12/09/2019 | 44.93% | HSBC | → $40 | Initiates Coverage On | → Buy |
| 11/25/2019 | 37.68% | Barclays | → $38 | Upgrades | Equal-Weight → Overweight |
| 11/22/2019 | 30.43% | Macquarie | → $36 | Initiates Coverage On | → Neutral |
| 11/21/2019 | 52.17% | Nomura | $40 → $42 | Maintains | Buy |
| 11/18/2019 | 37.68% | UBS | $36 → $38 | Maintains | Neutral |
| 11/18/2019 | 44.93% | UOB Kay Hian | → $40 | Upgrades | Hold → Buy |
| 11/18/2019 | 19.56% | Mizuho | $31 → $33 | Maintains | Neutral |
| 10/22/2019 | — | Vertical Research | Initiates Coverage On | → Buy | |
| 10/11/2019 | 48.55% | 86 Research | $35 → $41 | Upgrades | Hold → Buy |
| 08/19/2019 | 30.43% | Barclays | → $36 | Initiates Coverage On | → Equal-Weight |
| 08/14/2019 | 12.32% | Mizuho | $28 → $31 | Maintains | Neutral |
| 08/05/2019 | 32.25% | Jefferies | → $36.5 | Initiates Coverage On | → Buy |
| 06/04/2019 | — | Loop Capital | Initiates Coverage On | → Buy | |
| 05/15/2019 | — | Nomura | Upgrades | Neutral → Buy | |
| 05/13/2019 | — | CICC | Upgrades | Hold → Buy | |
| 04/30/2019 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 03/01/2019 | 12.32% | CLSA | $24 → $31 | Upgrades | Underperform → Outperform |
| 01/31/2019 | — | UBS | Downgrades | Buy → Neutral | |
| 12/13/2018 | -27.54% | Mizuho | → $20 | Assumes | → Neutral |
| 12/07/2018 | 26.81% | MKM Partners | $41 → $35 | Maintains | Buy |
| 11/20/2018 | -13.04% | Nomura | $41 → $24 | Downgrades | Buy → Neutral |
| 11/20/2018 | -13.04% | Macquarie | $35 → $24 | Downgrades | Outperform → Neutral |
What is the target price for JD.com (JD)?
The latest price target for JD.com (NASDAQ: JD) was reported by Benchmark on November 16, 2023. The analyst firm set a price target for $67.00 expecting JD to rise to within 12 months (a possible 142.75% upside). 31 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for JD.com (JD)?
The latest analyst rating for JD.com (NASDAQ: JD) was provided by Benchmark, and JD.com reiterated their buy rating.
When is the next analyst rating going to be posted or updated for JD.com (JD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of JD.com, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for JD.com was filed on November 16, 2023 so you should expect the next rating to be made available sometime around November 16, 2024.
Is the Analyst Rating JD.com (JD) correct?
While ratings are subjective and will change, the latest JD.com (JD) rating was a reiterated with a price target of $0.00 to $67.00. The current price JD.com (JD) is trading at is $27.60, which is within the analyst's predicted range.